Chrystal Capital

About The Fund

Founded in 2010 and based in London, United Kingdom, Chrystal Capital is a distinctive corporate finance and investment house with a strategic focus on the Cannabis and Life Science industries. They offer a range of financial advisory services and access to alternative sources of funding for selected private and public companies globally. The firm specializes in raising capital through avenues such as private placements, IPOs, rights issues, convertible bonds, and secondary equity issuance for public companies. Chrystal Capital prides itself on its extensive global network of Single Family Offices (SFOs), Ultra High Net Worth Individuals (UHNWIs), and private equity co-investment partners. This network acts as a conduit, providing bespoke solutions tailored to the capital and investment objectives of their members. The firm's core sectors include the Digital Economy, Health & Wellness, Sustainable & Impact Investments, and Natural Resources, with service areas spanning Advisory, Principal Investments, and Co-investments. Driven by values of enterprise, integrity, and quality, Chrystal Capital seeks to deliver clear outcomes by combining precise focus with entrepreneurial resourcefulness. They offer unique investment opportunities, the option to co-invest with like-minded entities, and provide corporate finance advice. With a commitment to integrity, the firm maintains trusted relationships and invests its own capital to align interests with clients and investors. Their quality-centric approach leverages specialist expertise in emerging and high-growth markets, aiming to uncover hidden value and offer high-quality investment opportunities to their network.